Published in Dtsch Med Wochenschr on June 07, 1991
Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) (2006) 3.40
Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet (1979) 2.14
Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.62
Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45
Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut (1986) 1.44
Protein-calorie malnutrition in liver cirrhosis. Clin Investig (1992) 1.26
Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation (1991) 1.13
Observations of enzyme elevations in the serum during streptokinase treatment. J Clin Pathol (1972) 1.13
Energy expenditure in children with type I diabetes: evidence for increased thermogenesis. BMJ (1989) 1.13
Characterization of new gibberellin-responsive semidwarf mutants of arabidopsis. Plant Physiol (1997) 1.09
Organic carbon-14 in the Amazon river system. Science (1986) 1.08
Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem (1987) 1.04
Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology (1992) 1.03
Results of an epidemiological survey of enzootic bovine leukosis in the northern part of Lower Saxony and a preliminary communication of an examination into relationship between BLV-antibody development and calving. Ann Rech Vet (1978) 1.02
Enzyme diagnosis of liver diseases. Clin Biochem (1993) 1.00
Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr (1999) 0.99
The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis. Hepatology (1996) 0.99
Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol (1991) 0.97
Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. Ther Drug Monit (1990) 0.97
Studies on the metabolic defect in Broad-beta disease (hyperlipoproteinaemia type III). Clin Genet (1977) 0.96
Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori. Gut (1992) 0.96
[Comparative serologic studies on leukemia viruses. Complement fixation reaction for the determination of common antigen components occurring in leukemia viruses of various mammals]. Z Naturforsch B (1970) 0.96
Creatine kinase (EC-No.2.7.3.2) and creatine kinase isoenzymes during pregnancy and labor and in the cord blood. Clin Biochem (1979) 0.93
Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr Clin Neurophysiol (1990) 0.91
Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials. J Hepatol (1986) 0.90
[Results of treating the acute stage of Crohn's disease by a dietary regimen (author's transl)]. Dtsch Med Wochenschr (1978) 0.90
Circadian pattern of intragastric acidity in duodenal ulcer patients: a study of variations in relation to ulcer activity. Gut (1991) 0.89
Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology (1992) 0.89
[The occurrence of the tumorons form of enzoctic bovine leukosis in Lower Saxony]. Dtsch Tierarztl Wochenschr (1970) 0.88
Glucose intolerance in liver cirrhosis: role of hepatic and non-hepatic influences. Eur J Clin Chem Clin Biochem (1994) 0.88
Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme. Clin Chim Acta (1988) 0.87
Total body water, extracellular water, plasma volume, and total body potassium in cirrhosis of the liver. Klin Wochenschr (1979) 0.86
Campylobacter pylori and gastric acidity. Am J Gastroenterol (1989) 0.86
The influence of colostral leukocytes on the immune system of the neonatal calf. I. Effects on lymphocyte responses. Dtsch Tierarztl Wochenschr (1991) 0.85
Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients. Metabolism (1993) 0.85
Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover. Klin Wochenschr (1988) 0.84
Energy expenditure and substrate metabolism in ethanol-induced liver cirrhosis. Am J Physiol (1991) 0.84
The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol (Copenh) (1989) 0.84
Campylobacter pylori and acid secretion. Lancet (1989) 0.84
Enzyme activities in human liver. Enzymol Biol Clin (Basel) (1970) 0.84
Rapid withdrawal of immunosuppressive therapy in chronic active hepatitis B infection. Lancet (1981) 0.84
[Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients]. Z Gastroenterol (1986) 0.83
Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology (1991) 0.83
[Epidemiology and therapy of Campylobacter pylori infection]. Dtsch Med Wochenschr (1989) 0.83
Tests of bile-acid and vitamin B12 metabolism in ileal Crohn's disease. Am J Clin Pathol (1980) 0.82
Gastric acid secretion and Campylobacter pylori. Gastroenterology (1988) 0.82
Whole-gut irrigation as antiendotoxinaemic therapy in inflammatory bowel disease. Hepatogastroenterology (1984) 0.82
Release of enzymes from the liver. Nature (1967) 0.82
Metabolic responses to lipid infusions in patients with liver cirrhosis. Clin Nutr (1992) 0.81
[Malignant peritoneal mesothelioma with unusual and extensive metastasis]. Dtsch Med Wochenschr (1991) 0.81
[Follow-up studies of the detection of IgG1 antibodies to Coxiella burnetii in blood and milk from cattle in relation to the reproductive cycle and milk production]. Dtsch Tierarztl Wochenschr (1994) 0.81
Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia. Hepatology (1998) 0.80
Thiols and hepatic coma. Artif Organs (1979) 0.80
Sex differences of plasma cholinesterase in the rat. Enzyme (1978) 0.80
[Cryptogenic multifocal stenosing enteritis]. Z Gastroenterol (1987) 0.80
[Letter: Hemoperfusion therapy of acute liver failure]. Dtsch Med Wochenschr (1976) 0.80
Clinical enzymology. FEBS Lett (1976) 0.80
Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score. Transplant Proc (1993) 0.80
HBV-vaccination in recipients of kidney allografts. Vaccine (1984) 0.80
Resting energy expenditure and nutritional state in patients with liver cirrhosis before and after liver transplantation. Clin Nutr (1994) 0.80
Percutaneous endoscopic gastrostomy in AIDS and control patients: risks and outcome. Am J Gastroenterol (1996) 0.80
Lipoprotein (a): a risk factor for retinal vascular occlusion. Ger J Ophthalmol (1992) 0.79
[Virus particles in leukocyte cultures of cattle experimentally infected with leukosis]. Dtsch Tierarztl Wochenschr (1970) 0.79
[In vivo dissolving of gall-stones: the effect of chenodeoxycholic acid. (author's transl)]. Dtsch Med Wochenschr (1975) 0.79
Effects of chronic alcohol abuse on the fatty acid composition of major lipids in the human brain. Hepatocerebral degeneration II. Z Klin Chem Klin Biochem (1973) 0.79
Energy expenditure and substrate metabolism in liver cirrhosis. Int J Obes Relat Metab Disord (1993) 0.79
[Normal values and aging of the main enzyme series in serum]. Klin Wochenschr (1966) 0.79
[Effect of leukosis control on the development of enzootic bovine leukosis in Lower Saxony]. Dtsch Tierarztl Wochenschr (1978) 0.78
Acute phase response and energy balance in stable human immunodeficiency virus-infected patients: a doubly labeled water study. J Lab Clin Med (2001) 0.78
Developments in liver transplantation. Jpn J Surg (1985) 0.78
"In vivo" distribution of liposomes between parenchymal and non parenchymal cells in rat liver. Biomedicine (1980) 0.78
[Comparison of peripheral parenteral feeding with an exclusively carbohydrate diet during the postoperative period]. Infusionsther Klin Ernahr (1977) 0.78
Intestinal lavage in the treatment of Crohn's disease: a pilot study. Klin Wochenschr (1982) 0.78
[Erythrohepatic protoporphyria with rapidly progressing liver cirrhosis]. Dtsch Med Wochenschr (1989) 0.78
The influence of colostral leukocytes on the immune system of the neonatal calf. II. Effects on passive and active immunization. Dtsch Tierarztl Wochenschr (1991) 0.78
Progress in the enzyme diagnosis of liver disease: reality or illusion? Clin Biochem (1990) 0.78
Standardization by reference methods: a German viewpoint. Clin Chim Acta (1988) 0.77
Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis. Clin Biochem (1985) 0.77
Studies of liver function and structure in patients with gallstones before and during treatment with chenodeoxycholic acid. Acta Hepatogastroenterol (Stuttg) (1975) 0.77
Metabolic, endocrine, haemodynamic and pulmonary responses to different types of exercise in individuals with normal or reduced liver function. Eur J Appl Physiol Occup Physiol (1996) 0.77
Are patients with liver cirrhosis hypermetabolic? Clin Nutr (1994) 0.77
Effect of liposome-entrapped methotrexate on Ehrlich ascites tumor cells and uptake in primary liver cell tumor. J Cancer Res Clin Oncol (1979) 0.77
Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. Lancet (1988) 0.76
[Aspects of enzyme diagnosis]. Med Welt (1970) 0.76
[Determination of creatine kinase and CK-MB in heart failure (author's transl)]. Med Klin (1978) 0.76
[Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites]. Klin Wochenschr (1989) 0.76